Abstract:Aims: We aim to explore the correlation between coronary artery calcification (CAC) score (CACS) and cardiac structure and function in chronic kidney disease (CKD) patients, create a clinical prediction model for severe CAC associated with cardiac ultrasound indexes. Methods and results: The study included 178 non-dialysis CKD patients who underwent CACS testing and collected general information, serological indices, cardiac ultrasound findings and follow-up on renal function, heart failure (HF) manifestations and re-hospitalization. The mean age of participants in the study cohort was 67.4 years; 59% were male, and 66.9% of patients had varying degrees of comorbid CAC. CKD patients with CACS > 100 were older, predominantly male and had a higher proportion of smoking, diabetes and hypertension (P < 0.05) compared with those with CACS = 0 and 0 < CACS ≤ 100, and had higher brain natriuretic peptide, serum magnesium and fibrinogen levels were also higher (P < 0.05). CACS was positively correlated with left atrial inner diameter (LAD), left ventricular end-diastolic inner diameter (LVDd), left ventricular volume at diastole (LVVd), output per beat (SV) and mitral orifice early diastolic blood flow velocity/early mitral annular diastolic myocardial motion velocity (E/e) (P < 0.05). We tested the associations between varying degrees of CAC and HF and heart valve calcification using multivariable-adjusted regression models. The risk of HF in patients with severe CAC was about 1.95 times higher than that in patients without coronary calcification, and the risk of heart valve calcification was 2.46 times higher than that in patients without coronary calcification. Heart valve calcification and HF diagnosis, LAD and LVDd are essential in predicting severe CAC. During a mean follow-up time of 18.26 ± 10.17 months, 65 (36.52%) patients had a composite renal endpoint event, of which 36 (20.22%) were admitted to renal replacement therapy. Patients with severe CAC had a higher risk of progression of renal function, re-admission due to cardiovascular and renal events and more pronounced symptoms of HF (P < 0.05). Conclusions: There is a correlation between CACS and cardiac structure and function in non-dialysis CKD patients, which may mainly involve abnormalities in left ventricular structure and cardiac diastolic function. CAC may affect renal prognosis and quality of survival in CKD patients. Based on clinical information, HF, valvular calcification status and indicators related to left ventricular hypertrophy can identify people at risk for severe CAC.

Correlation Between Serum Calcineurin Activity And Left Ventricular Hypertrophy In Hypertensive Patients And Its Clinical Significance

STUDY ON THE RELATIONSHIP BETWEEN LEFT VENTRICULAR GEOMETRY AND SERUM PROCOLLAGEN TYPE Ⅰ AND TYPE Ⅲ IN ESSENTIAL HYPERTENSIVE PATIENTS

Association of Central Arterial Blood Pressure and Left Ventricular Hypertrophy in Patients with Chronic Kidney Disease

Left Ventricular Geometry and the Levels of Plasma B-type Natriuretic Peptide and Serum Procollagen TypeⅢ in Essential Hypertensive Patients

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

Clinical correlation between Cystatin C and cardiac remodeling in hypertension and coronary heart disease

Influence Factors of Left Ventricular Hypertrophy in Incipient Lupus Nephritis Patients

Correlation between serum 25-hydroxyvitamin D level and left ventricular hypertrophy in elderly males

Uncontrolled hypertension is associated with coronary artery calcification and electrocardiographic left ventricular hypertrophy: a case-control study

Relationship Between Atrial Natriuretic Peptide ( ANP ) and Left Ventricular Hypertrophy , Blood Volume in Dialysis Patients

Cardiac Magnetic Resonance Assessment of Cardiac Function Across Chronic Kidney Disease Stages

Correlation between coronary calcification and cardiac structure in non-dialysis patients with chronic kidney disease

PS 17-37 URINARY SODIUM AND LEFT VENTRICULAR HYPERTROPHY IN CHINESE HYPERTENSIVE PATIENTS

A13501 Study on Correlation Between Plasma Homocysteinemia Level and Target Organ Damage in Patients with Primary Hypertension

Pressure overload promotes cystatin C secretion of cardiomyocytes to regulate the MAPK signaling pathway and mediate cardiac hypertrophy

Relationship of Serum Amino-Terminal Pro-B-natriuretic Peptide with Cardiovascular Disease and Malnutrition in Patients with Maintenance Hemodialysis

Correlation between serum vitamin D level and cardiac diastolic function in patients with essential hy‐ pertension／

Relationship Between Hypertensive Left Ventricular Hypertrophy and Levels of Endothelin and Nitric Oxide.

Association Between the Angiotensin II/Angiotensin (1-7) Imbalance and Left Ventricular Hypertrophy in Patients with Heart Failure

Association of Endothelial and Mild Renal Dysfunction with the Severity of Left Ventricular Hypertrophy in Hypertensive Patients

Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients